Publications
Detailed Information
Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kyubo | - |
dc.contributor.author | Chie, Eui Kyu | - |
dc.contributor.author | Han, Wonshik | - |
dc.contributor.author | Noh, Dong-Young | - |
dc.contributor.author | Park, In Ae | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.contributor.author | Ha, Sung W. | - |
dc.date.accessioned | 2012-05-29T08:36:40Z | - |
dc.date.available | 2012-05-29T08:36:40Z | - |
dc.date.created | 2021-01-13 | - |
dc.date.created | 2021-01-13 | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | Journal of Korean Medical Science, Vol.25 No.2, pp.235-239 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.other | 120744 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76573 | - |
dc.description.abstract | Prognostic value of p53 and bcl-2 expression on treatment outcome in breast cancer patients has been extensively evaluated, but the results were inconclusive. We evaluated the prognostic significance of these molecular markers in patients treated with breast conserving surgery and radiotherapy. One hundred patients whose immunostaining of p53 and bcl-2 expression was available among 125 patients who underwent radiotherapy after breast conserving surgery and axillary lymph node dissection were enrolled into this study. Eighty-seven patients also received adjuvant chemotherapy and/or hormonal therapy. Conventional clinicopathologic variables and treatment-related factors were also considered. The 5-yr loco-regional relapse-free and distant metastasis-free survival rates were 91.7% and 90.9%, respectively. On univariate analysis, age, T stage and the absence of bcl-2 & estrogen receptor (ER) expression were associated with loco-regional relapse-free survival. When incorporating these variables into Cox proportional hazard model, only bcl-2(-)/ER(-) phenotype was an adverse prognostic factor (P=0.018). As for the distant metastasis-free survival, age, T stage, and p53 expression were significant on univariate analysis. However, p53 expression was the only prognosticator on multivariate analysis (P=0.009). A bcl-2(-)/ER(-) phenotype and p53 expression are useful molecular markers predicting loco-regional relapse-free and distant metastasis-free survival, respectively, in patients treated with breast conserving surgery and radiotherapy. | - |
dc.language | 영어 | - |
dc.language.iso | en | ko_KR |
dc.publisher | 대한의학회 | - |
dc.title | Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 지의규 | - |
dc.contributor.AlternativeAuthor | 한원식 | - |
dc.contributor.AlternativeAuthor | 김태유 | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.contributor.AlternativeAuthor | 방영주 | - |
dc.contributor.AlternativeAuthor | 노동영 | - |
dc.contributor.AlternativeAuthor | 오도연 | - |
dc.identifier.doi | 10.3346/jkms.2010.25.2.235 | - |
dc.citation.journaltitle | Journal of Korean Medical Science | - |
dc.description.citedreference | Freedman GM, 2009, CANCER, V115, P946, DOI 10.1002/cncr.24094 | - |
dc.description.citedreference | Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8 | - |
dc.description.citedreference | Bidard FC, 2008, ANN ONCOL, V19, P1261, DOI 10.1093/annonc/mdn039 | - |
dc.description.citedreference | Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287 | - |
dc.description.citedreference | Rolland P, 2007, INT J CANCER, V120, P1311, DOI 10.1002/ijc.22430 | - |
dc.description.citedreference | Rakha EA, 2007, CANCER, V109, P25, DOI 10.1002/cncr.22381 | - |
dc.description.citedreference | Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664 | - |
dc.description.citedreference | Neri A, 2006, BREAST CANCER RES TR, V99, P77, DOI 10.1007/s10549-006-9183-2 | - |
dc.description.citedreference | Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719 | - |
dc.description.citedreference | Choi DH, 2005, CANCER J, V11, P404 | - |
dc.description.citedreference | Kim KJ, 2005, JPN J CLIN ONCOL, V35, P126, DOI 10.1093/jjcolyhi039 | - |
dc.description.citedreference | Cianfrocca M, 2004, ONCOLOGIST, V9, P606 | - |
dc.description.citedreference | Chen HHW, 2002, JPN J CLIN ONCOL, V32, P332 | - |
dc.description.citedreference | Alizadeh AA, 2001, J PATHOL, V195, P41 | - |
dc.description.citedreference | Turner BC, 2000, CANCER, V88, P1091 | - |
dc.description.citedreference | Le MG, 1999, INT J CANCER, V84, P562 | - |
dc.description.citedreference | Elkhuizen PHM, 1999, INT J RADIAT ONCOL, V45, P73 | - |
dc.description.citedreference | Berardo MD, 1998, CANCER, V82, P1296 | - |
dc.description.citedreference | Zhang GJ, 1997, JPN J CLIN ONCOL, V27, P371 | - |
dc.description.citedreference | Noguchi S, 1997, ONCOLOGY, V54, P468 | - |
dc.description.citedreference | Silvestrini R, 1997, J NATL CANCER I, V89, P639 | - |
dc.description.citedreference | BERGH J, 1995, NAT MED, V1, P1029 | - |
dc.description.citedreference | HELLEMANS P, 1995, BRIT J CANCER, V72, P354 | - |
dc.description.citedreference | GASPARINI G, 1995, CLIN CANCER RES, V1, P189 | - |
dc.description.citedreference | SILVESTRINI R, 1994, J NATL CANCER I, V86, P499 | - |
dc.description.citedreference | THOR AD, 1992, J NATL CANCER I, V84, P845 | - |
dc.description.tc | 3 | - |
dc.identifier.wosid | 000274413400007 | - |
dc.identifier.scopusid | 2-s2.0-77951633260 | - |
dc.citation.endpage | 239 | - |
dc.citation.number | 2 | - |
dc.citation.startpage | 235 | - |
dc.citation.volume | 25 | - |
dc.identifier.sci | 000274413400007 | - |
dc.identifier.kciid | ART001417170 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Chie, Eui Kyu | - |
dc.contributor.affiliatedAuthor | Han, Wonshik | - |
dc.contributor.affiliatedAuthor | Noh, Dong-Young | - |
dc.contributor.affiliatedAuthor | Park, In Ae | - |
dc.contributor.affiliatedAuthor | Oh, Do-Youn | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.contributor.affiliatedAuthor | Ha, Sung W. | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | CANCER PATIENTS | - |
dc.subject.keywordPlus | ADJUVANT RADIOTHERAPY | - |
dc.subject.keywordPlus | CONSERVING THERAPY | - |
dc.subject.keywordPlus | INDEPENDENT MARKER | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | CARCINOMAS | - |
dc.subject.keywordPlus | RADIATION | - |
dc.subject.keywordAuthor | Breast Neoplasms | - |
dc.subject.keywordAuthor | bcl-2 | - |
dc.subject.keywordAuthor | p53 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.